Placebo Inhaler
Sponsors
McNeil AB, Organon and Co, Teva Branded Pharmaceutical Products R&D, Inc., Allergan, Brigham and Women's Hospital
Conditions
AsthmaAsthma Placebo EffectsEosinophilic EsophagitisHealthyNicotine DependenceOsteoporosisSmoking Cessation
Phase 1
Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure
CompletedNCT01089062
Start: 2010-03-31End: 2010-12-31Updated: 2014-01-09
Corrected QT (QTc) Study With Flucticasone Furoate and GW642444
CompletedNCT01209026
Start: 2010-06-23End: 2011-01-04Updated: 2017-06-08
Phase 2
Phase 3
Smoking Reduction or Cessation With Nicotine Replacement Therapy
CompletedNCT00840242
Start: 1999-02-28End: 2000-05-31Updated: 2012-04-25
The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)
CompletedNCT00911547
Start: 1995-03-31End: 1996-05-31Updated: 2022-02-03
Phase 4
Nicotine Replacement for Smoking Cessation During Pregnancy
CompletedNCT01656733
Start: 2012-08-31End: 2017-10-25Updated: 2019-09-30
Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
CompletedNCT02019758
Start: 2015-01-01End: 2019-04-30Updated: 2020-04-27
The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton
WithdrawnNCT02357277
Start: 2015-03-31End: 2018-11-30Updated: 2017-07-18